Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study

BACKGROUND: Induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) is almost universally complicated by febrile neutropenia(FN). Empirical broad-spectrum antibiotic therapy (EBAT) strategies advocated by guidelines result in long periods of broad-spectrum antibioti...

Descripción completa

Detalles Bibliográficos
Autores principales: Schauwvlieghe, A., Dunbar, A., Storme, E., Vlak, A., Aerts, R., Maertens, J., Sciot, B., Van Der Wel, T., Papageorgiou, G., Moors, I., Cornelissen, J.J., Rijnders, B.J.A., Mercier, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099620/
https://www.ncbi.nlm.nih.gov/pubmed/33997746
http://dx.doi.org/10.1016/j.eclinm.2021.100855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099620/
https://www.ncbi.nlm.nih.gov/pubmed/33997746
http://dx.doi.org/10.1016/j.eclinm.2021.100855

Ejemplares similares